These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29076047)

  • 1. Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
    Batard E; Vibet MA; Thibaut S; Corvec S; Pivette J; Lepelletier D; Caillon J; Montassier E
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):271-276. PubMed ID: 29076047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
    Gottesman BS; Carmeli Y; Shitrit P; Chowers M
    Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
    Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
    Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?
    Strand L; Jenkins A; Henriksen IH; Allum AG; Grude N; Kristiansen BE
    BMC Res Notes; 2014 Jun; 7():376. PubMed ID: 24941949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.
    Pons MJ; Mosquito S; Gomes C; Del Valle LJ; Ochoa TJ; Ruiz J
    Trans R Soc Trop Med Hyg; 2014 Jan; 108(1):22-8. PubMed ID: 24306130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
    Jeanvoine A; Bouxom H; Leroy J; Gbaguidi-Haore H; Bertrand X; Slekovec C
    Int J Antimicrob Agents; 2020 May; 55(5):105909. PubMed ID: 31991220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone resistance and correlation to other antimicrobial resistances in faecal isolates of Escherichia coli in Hong Kong.
    Chu YW; Cheung TK; Wong CH; Tsang GK; Lee K; Lau SS; Kam KM
    Chemotherapy; 2008; 54(4):274-8. PubMed ID: 18667817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone resistance in absence of selective pressure: the experience of a very remote community in the Amazon forest.
    Pallecchi L; Bartoloni A; Riccobono E; Fernandez C; Mantella A; Magnelli D; Mannini D; Strohmeyer M; Bartalesi F; Rodriguez H; Gotuzzo E; Rossolini GM
    PLoS Negl Trop Dis; 2012; 6(8):e1790. PubMed ID: 22953012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of plasmid-mediated qnr genes among the quinolone-resistant Escherichia coli isolates in Iran.
    Firoozeh F; Zibaei M; Soleimani-Asl Y
    J Infect Dev Ctries; 2014 Jul; 8(7):818-22. PubMed ID: 25022290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria.
    Betitra Y; Teresa V; Miguel V; Abdelaziz T
    Asian Pac J Trop Med; 2014 Jun; 7(6):462-7. PubMed ID: 25066395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
    González-Soltero R; García-Cañas A; Mohedano RB; Mendoza-Chamizo B; Botello E
    Rev Esp Quimioter; 2015 Jun; 28(3):139-44. PubMed ID: 26032998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Exposure in the Community and Resistance Patterns of Escherichia coli Community-Acquired Bloodstream Infection.
    Gottesman BS; Shitrit P; Katzir M; Chowers M
    Isr Med Assoc J; 2018 Jun; 20(6):382-384. PubMed ID: 29911761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.